|
[1]
|
Bhattacharjee, S., Siyad, I. and Maramattom, B. (2022) Chronic Diarrhea—The Poetic Masquerade. Journal of Postgraduate Medicine, 68, 239-242. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Li, J. and Zhou, D. (2013) New Advances in the Diagnosis and Treatment of POEMS Syndrome. British Journal of Haematology, 161, 303-315. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Dispenzieri, A. (2021) POEMS Syndrome: 2021 Update on Diagnosis, Risk‐Stratification, and Management. American Journal of Hematology, 96, 872-888. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Li, J., Zhang, W., Jiao, L., Duan, M., Guan, H., Zhu, W., et al. (2011) Combination of Melphalan and Dexamethasone for Patients with Newly Diagnosed POEMS Syndrome. Blood, 117, 6445-6449. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kourelis, T.V., Buadi, F.K., Kumar, S.K., Gertz, M.A., Lacy, M.Q., Dingli, D., et al. (2016) Long‐Term Outcome of Patients with POEMS Syndrome: An Update of the Mayo Clinic Experience. American Journal of Hematology, 91, 585-589. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Nozza, A., Terenghi, F., Gallia, F., Adami, F., Briani, C., Merlini, G., et al. (2017) Lenalidomide and Dexamethasone in Patients with poems Syndrome: Results of a Prospective, Open‐label Trial. British Journal of Haematology, 179, 748-755. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Misawa, S., Sato, Y., Katayama, K., Nagashima, K., Aoyagi, R., Sekiguchi, Y., et al. (2016) Safety and Efficacy of Thalidomide in Patients with POEMS Syndrome: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial. The Lancet Neurology, 15, 1129-1137. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Giglia, F., Chiapparini, L., Fariselli, L., Barbui, T., Ciano, C., Scarlato, M., et al. (2007) POEMS Syndrome: Relapse after Successful Autologous Peripheral Blood Stem Cell Transplantation. Neuromuscular Disorders, 17, 980-982. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Vaz, J.A., Frada, L., Soares, M.M., Mello, E. and Silva, A. (2020) POEMS Syndrome: An Atypical Presentation with Chronic Diarrhoea and Asthenia. European Journal of Case Reports in Internal Medicine, 7, Article ID: 001241.
|
|
[10]
|
Thakral, S., Issa, N.P., Barboi, A.C. and Lee, J.M. (2016) Prominent Dysautonomia in a Patient with POEMS Syndrome. Clinical Autonomic Research, 26, 223-228. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Fujinuma, Y., Asahina, M., Fukushima, T., Katagiri, A., Yamanaka, Y., Misawa, S., et al. (2012) Preserved Autonomic Function in Patients with POEMS Syndrome. Journal of the Neurological Sciences, 318, 131-134. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Kihara, Y., Hori, H., Murakami, H., Hatakeyama, Y., Yoshikawa, I., Hamada, T., et al. (2002) A Case of POEMS Syndrome Associated with Reactive Amyloidosis and Waldenström’s Macroglobulinaemia. Journal of Internal Medicine, 252, 255-258. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kuwabara, S., Suichi, T. and Misawa, S. (2020) ‘Early VEGF Testing in Inflammatory Neuropathy Avoids POEMS Syndrome Misdiagnosis and Associated Costs’ by Marsh et al. Journal of Neurology, Neurosurgery & Psychiatry, 92, 118-119. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Watanabe, O., Arimura, K., Kitajima, I., Osame, M. and Maruyama, I. (1996) Greatly Raised Vascular Endothelial Growth Factor (VEGF) in POEMS Syndrome. The Lancet, 347, 702. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Imai, N., Taguchi, J., Yagi, N., Konishi, T., Serizawa, M. and Kobari, M. (2009) Relapse of Polyneuropathy, Organomegaly, Endocrinopathy, M-Protein, and Skin Changes (POEMS) Syndrome without Increased Level of Vascular Endothelial Growth Factor Following Successful Autologous Peripheral Blood Stem Cell Transplantation. Neuromuscular Disorders, 19, 363-365. [Google Scholar] [CrossRef] [PubMed]
|